147 A Prospective Phase II, Open-Label, Single-arm, Multicenter Study to Assess the Efficacy and Safety of SEG101 (Crizanlizumab) in Sickle Cell Disease Patients With Priapism (SPARTAN)

Autor:	Das Purkayastha, Gregory J. Kato, Jincy Paulose, F. El Rassi, Arthur L. Burnett, Deepika S. Darbari, D. Lainé
Rok vydání:	2020
Předmět:	medicine.medical_specialty business.industry Urology Endocrinology Diabetes and Metabolism Priapism Disease medicine.disease Psychiatry and Mental health Endocrinology Reproductive Medicine Multicenter study medicine Open label business
Zdroj:	The Journal of Sexual Medicine. 17:S43-S43
ISSN:	1743-6109 1743-6095
DOI:	10.1016/j.jsxm.2019.11.092
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::0d331bfd1d2d6ba3a60bb487aac34df0 https://doi.org/10.1016/j.jsxm.2019.11.092 Zobrazit plný text záznamu